Dr. Dino Prato of Envita Medical Centers Geared Towards Providing Outcome-Driven Care With an Innovative Health Program
Awareness and accessibility to optimal outcome-driven results in every area of healthcare, and not just cancer care, is the focus of Dr. Dino Prato, Founder and CEO, Envita Medical Centers. In an article titled “7 cancer leaders on their goals for 2024,” published by Becker's Hospital Review, Dr. Prato, said “We have seen many patients suffer due to financial constraints in seeking the most appropriate care as well as the lack of awareness about the available treatment options, despite having health insurance coverage.”
The leader of this personalized precision integrative oncology facility explained that health insurance programs with high premiums or low deductibles do not necessarily open doorways for patients to access the latest treatment options or receive outcome-driven care. “My primary goal for 2024 is to reverse that trend and liberate Americans from the myriad of health insurance restrictions, allowing them to get coverage for a wider range of treatment options, which are designed to save and extend life spans, improve quality of life, as well as save precious time and money,” added Dr. Prato.
To work towards that goal, Dr. Prato is launching Envita Health, an innovative health insurance program, which is the first integrative precision medicine network in the United States, covering not only the latest in conventional medicine but also alternative and functional medicine. The Envita Health program has been designed by doctors themselves to go beyond the standard health insurance programs for providing value-based care, aimed at lasting outcomes.
With Envita Health, an open network program, members can receive all the benefits offered by standard health insurance programs along with other special offerings, such as, access to Centers of Excellence (COE) for specialized care, concierge care navigation for guiding patients to the best treatment options, custom-developed wellness plans based on advanced AI (Artificial Intelligence) data, and an expansive pharmacy program for discount-priced medications and custom compounded pharmaceuticals.
To know more about Envita Health and how it helps every American to access not just the latest in cancer research, but in every area of healthcare, read this article here.
* The 3rd party actuarial response data is based on an analysis 87 out of 129 patients that participated in Envita's Treatment Program in 2020. 42 patients were removed from the cohort due to the patients' inability to start or complete Envita's prescribed treatment for a variety of reasons, including advanced disease state, disease progression or inability to travel.